AVIENCE BIOMEDICALS LTD Financial Ratios
AVIENCE · Healthcare · Current price ₹222.85
P/E ratio
15.7x
P/B ratio
1.8x
ROE
25.3%
ROCE
21.1%
Debt / Equity
1.29
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 15.7x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 1.8x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 25.3% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 21.1% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 1.29 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with AVIENCE BIOMEDICALS LTD's latest numbers.
AVIENCE BIOMEDICALS LTD profitability
AVIENCE BIOMEDICALS LTD generates a return on equity of 25.3% and a return on capital employed of 21.1%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 1.29 and a P/E of 15.7x, AVIENCE BIOMEDICALS LTD is moderately leveraged. Our overall business-quality score for the company is 5.2 / 10.
Understand the ratios
More on AVIENCE BIOMEDICALS LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.